EUVIMEDEUVIMED entdecken
CrossrefInfokarte

The KISS1R gene rs350132 variant is significantly associated with central precocious puberty susceptibility among Asian girls: evidence from a case-control study and a meta-analysis

Boyu Li, Xinyi Zhang, Weiguang Zhou, Yuping Chu, Jiangyi Ruan, Siqi Yuan, Qinyue Yang, Jiaxuan Dai, Qiantao Xiong, Bifeng Chen

Annals of Pediatric Endocrinology & Metabolism · 2026-10-31 · 31 (5) · 301-309

DOI: 10.6065/apem.2550456.228 ↗
AbstractBibliografische Angaben

Abstract

Purpose: Kisspeptin receptor (KISS1R) plays a central regulatory role in the hypothalamic-pituitary-gonadal (HPG) axis, whose premature activation has been implicated in the pathogenesis of central precocious puberty (CPP). This study aimed to evaluate the contributions of 3 widely studied KISS1R gene variants (rs184749, rs350132, and rs3746146) to CPP susceptibility.Methods: Sanger sequencing was used to genotype the KISS1R gene variants in 422 healthy girls and 384 CPP girls, all from Hubei Province. Moreover, data from previous related studies and the present study were pooled in a meta-analysis.Results: The case-control study showed that the rs184749 G allele (P=0.004; odds ratio [OR], 1.42; 95% confidence interval [CI], 1.12–1.79) and the rs350132 A allele (P=0.007; OR, 1.38; 95% CI, 1.09–1.75) were associated with increased CPP susceptibility, and the GAC haplotype carrying rs184749(G) and rs350132(A) was associated with increased CPP risk among Hubei Chinese girls (P=0.005; OR, 1.44; 95% CI, 1.12–1.86). The subsequent meta-analysis confirmed the association of rs350132 with CPP susceptibility in Asian girls under the A versus T and AA versus AT+TT genetic models. The expression quantitative trait locus analysis revealed that KISS1R mRNA expression differed across rs350132 genotypes in several tissues.Conclusion: The present findings suggest that the KISS1R variant rs350132 may serve as a susceptibility locus in CPP pathogenesis among Asian girls; this finding warrants confirmation in future studies.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →